Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
about
Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.Receptor-interacting protein kinase 3-mediated programmed cell necrosis in rats subjected to focal cerebral ischemia-reperfusion injuryNovel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice.Improvement of postoperative cognitive dysfunction and attention network function of patients with ischemic cerebrovascular disease via dexmedetomidine.
P2860
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@ast
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@en
type
label
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@ast
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@en
prefLabel
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@ast
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@en
P2093
P2860
P3181
P356
P1433
P1476
Pharmacologically targeted NMD ...... ne for cerebrovascular disease
@en
P2093
Dongxian Zhang
Emily A Holland
Hiroto Takahashi
James W Larrick
Jiankun Cui
Juan Piña-Crespo
Karthik Bodhinathan
Maria Talantova
Nobuki Nakanishi
P2860
P2888
P3181
P356
10.1038/SREP14781
P407
P577
2015-10-19T00:00:00Z
P5875
P6179
1028935940